Associate Director, Pharmacovigilance Scientist

Posted 5 Days Ago
Be an Early Applicant
Boston, MA, USA
In-Office
162K-242K Annually
Senior level
Biotech
The Role
Leads pharmacovigilance and drug safety activities across clinical development and commercialization. Responsibilities include signal detection, literature reviews, benefit-risk assessments, safety governance, aggregate safety report authorship, clinical document review, risk management, regulatory compliance, audits, inspections, and collaboration with cross-functional and partner teams.
Summary Generated by Built In

Company Overview

Tango Therapeutics is a biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer.

Using an approach that starts and ends with patients, Tango leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at critical targets in cancer.

This includes expanding the universe of precision oncology targets into novel areas such as tumor suppressor gene loss and their contribution to the ability of cancer cells to evade immune cell killing.

The Tango labs and offices are located at 201 Brookline Avenue, in the Fenway area of Boston, Massachusetts.

Summary

The Associate Director, Pharmacovigilance Scientist, reporting to the Senior Director, Drug Safety, plays a pivotal role, partnering closely across the organization to evaluate drug safety data, manage adverse event signals and author regulatory safety reports across the product lifecycle from first-in-human studies through global registration and commercialization.

This role is responsible for high-quality safety surveillance activities including aggregate report production, safety governance meeting coordination, safety signal detection and assessment and safety risk management activities for assigned Tango products. 

This role is accountable for proactively and continuously evaluating and clearly communicating benefit-risk profiles across the product lifecycle—ensuring alignment with global regulatory expectations, pharmacovigilance standards, and industry best practices, while enabling confident, data-driven development and commercialization decisions.

Your Role

  • Lead and oversee ongoing safety surveillance (including signal detection activities and literature reviews) for assigned programs, ensuring compliance with global regulatory requirements and company objectives
  • Contribute as the safety subject matter expert for assigned programs, driving benefit-risk assessment, signal detection, risk management, and safety governance in partnership with drug safety leadership and cross-functional teams
  • Author and contribute to key safety deliverables, including DSURs, PSURs/PBRERs, Safety Assessment Reports for potential signals/risks, Reference Safety Information (RSI) and ADR in the DCSI/CCSI
  • Provide safety review and contribute to various clinical trial documents including but not limited to protocols, informed consent forms, Investigator’s Brochure
  • Provide analyses and presentation of safety data and messages to define the product risk profile and inform risk management
  • Partner with the Pharmacovigilance Operations team to enhance, and maintain a scalable global drug safety and pharmacovigilance framework supporting both clinical development and post-marketing activities
  • Contribute to the development and optimization of new tools and processes by applying industry best practices, emerging methodologies, and evolving trends in pharmacovigilance, signal detection, and benefit-risk management
  • Contribute to the planning and conduct of safety committee and data monitoring committee activities
  • Collaborate with Partner for co-development or co-marketing, when applicable, with regards to drug safety related activities
  • Ensure compliance with regulatory guidelines and internal processes and procedures in preparation of audits and inspections
  • Participate in audit and inspection activities, as required
  • Maintain up-to-date knowledge of relevant current FDA, ICH guidelines, EU PV regulations and other PV legislation globally

What You Bring

  • 8+ years of drug safety and pharmacovigilance experience within the biotechnology and/or pharmaceutical industry with at least 3 years in pharmacovigilance sciences
  • Bachelor’s degree in a scientific or health care related discipline required, advanced degree (MS, PharmD, PhD, MD, RN) strongly preferred
  • Strong drug safety and regulatory knowledge, ideally in oncology
  • Skilled in signal detection processes and managing safety information across the product life cycle
  • Experience authoring aggregates safety reports including DSURs, PSURs/PBRERs and safety-related sections of clinical trial documents such as IB and RSI
  • Demonstrated expertise in global PV regulations, GVP and ICH guidelines, safety systems and drug development processes
  • Ability to translate complex safety data into actionable recommendations and identify alternative solutions for regulatory and clinical decision-making.
  • Experience in regulatory submissions for marketing license applications in the US and in EU preferred
  • Self-motivated, flexible, able to prioritize, multitask and work in a fast-paced and demanding environment.
  • Strong organizational and project management skills
  • Excellent communication and cross-functional collaboration skills


We are an equal opportunity employer and value diversity at our company. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.



Salary range
$161,600$242,400 USD

Skills Required

  • 8+ years of drug safety and pharmacovigilance experience in the biotechnology or pharmaceutical industry, including at least 3 years in pharmacovigilance sciences
  • Bachelor's degree in a scientific or healthcare-related discipline
  • Advanced degree such as MS, PharmD, PhD, MD, or RN
  • Strong drug safety and regulatory knowledge, ideally in oncology
  • Experience with signal detection processes and safety information management across the product lifecycle
  • Experience authoring DSURs, PSURs/PBRERs, and safety sections of clinical trial documents, including Investigator's Brochures and Reference Safety Information
  • Expertise in global pharmacovigilance regulations, GVP and ICH guidelines, safety systems, and drug development processes
  • Ability to translate complex safety data into actionable recommendations for regulatory and clinical decision-making
  • Experience with regulatory submissions for marketing license applications in the United States and European Union
  • Ability to prioritize, multitask, and work in a fast-paced, demanding environment
  • Strong organizational and project management skills
  • Excellent communication and cross-functional collaboration skills
Am I A Good Fit?
beta
Get Personalized Job Insights.
Our AI-powered fit analysis compares your resume with a job listing so you know if your skills & experience align.

The Company
HQ: Cambridge, MA
157 Employees
Year Founded: 2017

What We Do

Tango Therapeutics is a biotechnology company discovering and developing novel medicines targeting cancer vulnerabilities to deliver transformational new therapies for patients. Tango was launched in 2017 with a $55 million Series A investment from Third Rock Ventures. The company has established a robust product engine that leverages advances in DNA sequencing and CRISPR-based target discovery to generate breakthrough medicines that have the potential to provide deeper, more sustained benefit than today’s targeted therapies, and extend the benefit of available immuno-oncology agents. Tango Therapeutics is focused on three areas of drug development, each in well-defined patient populations currently lacking effective treatment options, and each with hallmarks of cancer that have not been targeted yet. These include: loss of tumor suppressor gene function; multiple oncogenic drivers; and immune evasion. What fuels each of Tango’s programs is an increasingly sophisticated ability to utilize synthetic lethality - the interaction between two genes that causes cell death when both are inactivated. In cancer cells, one of these genes is inactivated by mutation; the other will be inactivated by a drug. This approach leaves normal cells largely unaffected, with the potential to greatly enhance anti-tumor efficacy and reduce associated toxicity. Tango’s success will be driven by its depth of understanding of the genetic subtypes of cancer, and corresponding insights into novel drug targets and combinations uniquely relevant to each subtype. By shaping discovery efforts in this way, Tango has the potential to reach the clinic quickly, and with a clear plan for identifying the patients most likely to benefit from each new treatment, an approach that could increase both speed and probability of success in translating novel target discoveries into transformational new medicines for patients.

Similar Jobs

MongoDB Logo MongoDB

Senior Manager, HR Compliance - Americas

Big Data • Cloud • Software • Database
Easy Apply
Remote or Hybrid
United States
5550 Employees
81K-160K Annually

Tulip Logo Tulip

Business Development Representative

Enterprise Web • Hardware • Internet of Things • Software
Easy Apply
Hybrid
Somerville, MA, USA
310 Employees
55K-85K Annually

Liberty Mutual Insurance Logo Liberty Mutual Insurance

Inside Sales Representative

Artificial Intelligence • Fintech • Insurance • Marketing Tech • Software • Analytics
Remote or Hybrid
10 Locations
40000 Employees
45K-85K Annually

SOPHiA GENETICS Logo SOPHiA GENETICS

Director, Strategic Accounts - Health Systems

Artificial Intelligence • Big Data • Healthtech • Software • Biotech
Hybrid
Boston, MA, USA
450 Employees
112K-204K Annually

Similar Companies Hiring

Formation Bio Thumbnail
Artificial Intelligence • Big Data • Healthtech • Biotech • Pharmaceutical
New York, NY
150 Employees
SOPHiA GENETICS Thumbnail
Software • Healthtech • Biotech • Big Data • Artificial Intelligence
Boston, MA
450 Employees
Pfizer Thumbnail
Artificial Intelligence • Healthtech • Machine Learning • Natural Language Processing • Biotech • Pharmaceutical
New York, NY
121990 Employees

Sign up now Access later

Create Free Account

Please log in or sign up to report this job.

Create Free Account